Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Risk factors for developing oral 5-aminolevulinic acid-induced side effects in patients undergoing fluorescence guided resection.

Chung IW, Eljamel S.

Photodiagnosis Photodyn Ther. 2013 Dec;10(4):362-7. doi: 10.1016/j.pdpdt.2013.03.007. Epub 2013 Apr 29.

PMID:
24284086
2.

The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).

Inoue K, Matsuyama H, Fujimoto K, Hirao Y, Watanabe H, Ozono S, Oyama M, Ueno M, Sugimura Y, Shiina H, Mimata H, Azuma H, Nagase Y, Matsubara A, Ito YM, Shuin T.

Photodiagnosis Photodyn Ther. 2016 Mar;13:91-6. doi: 10.1016/j.pdpdt.2015.12.011. Epub 2016 Jan 2.

PMID:
26751700
3.

A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.

Lau D, Hervey-Jumper SL, Chang S, Molinaro AM, McDermott MW, Phillips JJ, Berger MS.

J Neurosurg. 2016 May;124(5):1300-9. doi: 10.3171/2015.5.JNS1577. Epub 2015 Nov 6.

PMID:
26544781
4.

Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.

Stummer W, Tonn JC, Mehdorn HM, Nestler U, Franz K, Goetz C, Bink A, Pichlmeier U; ALA-Glioma Study Group.

J Neurosurg. 2011 Mar;114(3):613-23. doi: 10.3171/2010.3.JNS097. Epub 2010 Apr 16.

PMID:
20397896
5.

Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.

Valdés PA, Jacobs V, Harris BT, Wilson BC, Leblond F, Paulsen KD, Roberts DW.

J Neurosurg. 2015 Sep;123(3):771-80. doi: 10.3171/2014.12.JNS14391. Epub 2015 Jul 3.

6.

5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.

Ackroyd R, Brown N, Vernon D, Roberts D, Stephenson T, Marcus S, Stoddard C, Reed M.

Photochem Photobiol. 1999 Oct;70(4):656-62.

PMID:
10546561
7.

Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.

Tsugu A, Ishizaka H, Mizokami Y, Osada T, Baba T, Yoshiyama M, Nishiyama J, Matsumae M.

World Neurosurg. 2011 Jul-Aug;76(1-2):120-7. doi: 10.1016/j.wneu.2011.02.005.

PMID:
21839963
8.

Oral 5-aminolevulinic acid induced Photodynamic Diagnostic Ureterorenoscopy--does the blood pressure require monitoring?

Bondad J, Aboumarzouk OM, Moseley H, Kata SG.

Photodiagnosis Photodyn Ther. 2013 Feb;10(1):39-41. doi: 10.1016/j.pdpdt.2012.06.004. Epub 2012 Jul 28.

PMID:
23465371
9.

Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.

Suzuki T, Wada S, Eguchi H, Adachi J, Mishima K, Matsutani M, Nishikawa R, Nishiyama M.

J Neurosurg. 2013 Nov;119(5):1331-9. doi: 10.3171/2013.7.JNS122340. Epub 2013 Sep 6.

PMID:
24010971
10.

Evaluation of the risk of liver damage from the use of 5-aminolevulinic acid for intra-operative identification and resection in patients with malignant gliomas.

Offersen CM, Skjoeth-Rasmussen J.

Acta Neurochir (Wien). 2017 Jan;159(1):145-150. doi: 10.1007/s00701-016-3014-y. Epub 2016 Nov 10.

PMID:
27832337
11.

Side effects and photosensitization of human tissues after aminolevulinic acid.

Webber J, Kessel D, Fromm D.

J Surg Res. 1997 Feb 15;68(1):31-7.

PMID:
9126192
12.

Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.

Bissonnette R, Zeng H, McLean DI, Korbelik M, Lui H.

Photochem Photobiol. 2001 Aug;74(2):339-45.

PMID:
11547574
13.

Experimental use of photodynamic therapy in high grade gliomas: a review focused on 5-aminolevulinic acid.

Tetard MC, Vermandel M, Mordon S, Lejeune JP, Reyns N.

Photodiagnosis Photodyn Ther. 2014 Sep;11(3):319-30. doi: 10.1016/j.pdpdt.2014.04.004. Epub 2014 Jun 4. Review.

PMID:
24905843
14.

Low dose 5-aminolevulinic acid: Implications in spectroscopic measurements during brain tumor surgery.

Haj-Hosseini N, Richter JC, Hallbeck M, Wårdell K.

Photodiagnosis Photodyn Ther. 2015 Jun;12(2):209-14. doi: 10.1016/j.pdpdt.2015.03.004. Epub 2015 Mar 26.

PMID:
25818546
15.

Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.

Millesi M, Kiesel B, Woehrer A, Hainfellner JA, Novak K, Martínez-Moreno M, Wolfsberger S, Knosp E, Widhalm G.

Neurosurg Focus. 2014 Feb;36(2):E11. doi: 10.3171/2013.12.FOCUS13485.

PMID:
24484249
16.

Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA.

Stummer W, Nestler U, Stockhammer F, Krex D, Kern BC, Mehdorn HM, Vince GH, Pichlmeier U.

J Neurooncol. 2011 Jun;103(2):361-70. doi: 10.1007/s11060-010-0400-9. Epub 2010 Oct 5.

PMID:
20922459
17.

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of brain tumors in children--a technical report.

Beez T, Sarikaya-Seiwert S, Steiger HJ, Hänggi D.

Acta Neurochir (Wien). 2014 Mar;156(3):597-604. doi: 10.1007/s00701-014-1997-9. Epub 2014 Jan 22.

PMID:
24449149
18.
20.

Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.

Reulen HJ, Poepperl G, Goetz C, Gildehaus FJ, Schmidt M, Tatsch K, Pietsch T, Kraus T, Rachinger W.

J Neurosurg. 2015 Sep;123(3):760-70. doi: 10.3171/2014.12.JNS142168. Epub 2015 Jul 3.

PMID:
26140493

Supplemental Content

Support Center